![AbbVie's Humira needs a discount, ICER says, warning Lilly, Sanofi to price with care | Fierce Pharma AbbVie's Humira needs a discount, ICER says, warning Lilly, Sanofi to price with care | Fierce Pharma](https://qtxasset.com/quartz/qcloud5/media/image/2016-09/humiragood.jpg?VersionId=IMHQKeP3FEsbi1KzkE2Lmb6oS2BKDhtf)
AbbVie's Humira needs a discount, ICER says, warning Lilly, Sanofi to price with care | Fierce Pharma
![HUMIRA Price | Price List or Cost of Generic adalimumab | treatment of rheumatoid arthritis | Price in India HUMIRA Price | Price List or Cost of Generic adalimumab | treatment of rheumatoid arthritis | Price in India](https://specialitypharma.com/assets/img/medicines/humira-adalimumab.jpg)
HUMIRA Price | Price List or Cost of Generic adalimumab | treatment of rheumatoid arthritis | Price in India
![A Humira Prescription Costs $38,000 A Year Because Our Patent System Is Being Abused | HuffPost Opinion Archive A Humira Prescription Costs $38,000 A Year Because Our Patent System Is Being Abused | HuffPost Opinion Archive](https://img.huffingtonpost.com/asset/5bd0ca34260000450283e139.jpeg?cache=6aDrhpnfiW&ops=1778_1000)
A Humira Prescription Costs $38,000 A Year Because Our Patent System Is Being Abused | HuffPost Opinion Archive
![Humira rings up $20.7B in 2021, but AbbVie still mum on post-biosimilar expectations | Fierce Pharma Humira rings up $20.7B in 2021, but AbbVie still mum on post-biosimilar expectations | Fierce Pharma](https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1643820639/large.img_.png/large.img_.png?VersionId=Qe.Z8MhPo8.UNbqc4s7d3.fQ8QAisbYS)
Humira rings up $20.7B in 2021, but AbbVie still mum on post-biosimilar expectations | Fierce Pharma
![Cigna's PBM Express Scripts Latest To Put Less Pricey Biosimilars Of Abbvie's Humira On Preferred Drug List Cigna's PBM Express Scripts Latest To Put Less Pricey Biosimilars Of Abbvie's Humira On Preferred Drug List](https://imageio.forbes.com/specials-images/imageserve/638e100858538955d5570670/0x0.jpg?format=jpg&width=1200)
Cigna's PBM Express Scripts Latest To Put Less Pricey Biosimilars Of Abbvie's Humira On Preferred Drug List
![Amgen Adopts A Two-Price Strategy For The U.S.'s First Marketed Humira-Referenced Biosimilar, Amjevita Amgen Adopts A Two-Price Strategy For The U.S.'s First Marketed Humira-Referenced Biosimilar, Amjevita](https://imageio.forbes.com/specials-images/imageserve/63d9a6e23615b0bf6a3e9f12/Earns-AbbVie/960x0.jpg?format=jpg&width=960)
Amgen Adopts A Two-Price Strategy For The U.S.'s First Marketed Humira-Referenced Biosimilar, Amjevita
![Frontiers | A Patients' Perspective Towards the Injection Devices for Humira® and Imraldi® in a Nationwide Switching Program Frontiers | A Patients' Perspective Towards the Injection Devices for Humira® and Imraldi® in a Nationwide Switching Program](https://www.frontiersin.org/files/Articles/799494/fmed-09-799494-HTML/image_m/fmed-09-799494-t001.jpg)
Frontiers | A Patients' Perspective Towards the Injection Devices for Humira® and Imraldi® in a Nationwide Switching Program
![AbbVie, Humira among products, companies facing penalty under drug pricing rule | Crain's Chicago Business AbbVie, Humira among products, companies facing penalty under drug pricing rule | Crain's Chicago Business](https://s3-prod.chicagobusiness.com/4423388174_c80ca733ea_o_0.jpg)